Ph2 readouts in Q1 2024...

$Pfizer(PFE.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2
$Vera Therapeutics(VERA.US)$ Phase 2b
$4D Molecular Therapeutics(FDMT.US)$ Phase 2
$Adverum Biotechnologies(ADVM.US)$ Phase 2
$Denali Therapeutics(DNLI.US)$ Phase 2
$Akero Therapeutics(AKRO.US)$ Phase 2b
$Spruce Biosciences(SPRB.US)$ Phase 2
$Xencor(XNCR.US)$ Phase 2
$Alnylam Pharmaceuticals(ALNY.US)$ Phase 2
$Harmony Biosciences(HRMY.US)$ Phase 2
$Annexon(ANNX.US)$ Phase 2a
$Roivant Sciences(ROIV.US)$ Phase 2
$TFF Pharmaceuticals(TFFP.US)$ Phase 2
$Cogent Biosciences(COGT.US)$ Phase 2
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 2
$TFF Pharmaceuticals(TFFP.US)$ Phase 2
$Fusion Pharmaceuticals(FUSN.US)$ Phase 2
$Amgen(AMGN.US)$ Phase 2
$Tarsus Pharmaceuticals(TARS.US)$ Phase 2a
$Aslan Pharmaceuticals(ASLN.US)$ Phase 2
$MoonLake Immunotherapeutics(MLTX.US)$ Phase 2
$Clene(CLNN.US)$ Phase 2
$Altimmune(ALT.US)$ Phase 2
$Spruce Biosciences(SPRB.US)$ Phase 2
$Ironwood Pharmaceuticals(IRWD.US)$ Phase 2a
$Tarsus Pharmaceuticals(TARS.US)$ Phase 2a
$G1 Therapeutics(GTHX.US)$ Phase 2
$Leap Therapeutics(LPTX.US)$ Phase 2a
$Sagimet Biosciences(SGMT.US)$ Phase 2b
$Inventiva(IVA.US)$ Phase 2a
$Larimar Therapeutics(LRMR.US)$ Phase 2
$AC Immune(ACIU.US)$ Phase 2
$Innate Pharma(IPHA.US)$ Phase 2
$Intensity Therapeutics(INTS.US)$ Phase 2
$ATAI Life Sciences(ATAI.US)$ Phase 2